SG11201701104SA - Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride - Google Patents

Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride

Info

Publication number
SG11201701104SA
SG11201701104SA SG11201701104SA SG11201701104SA SG11201701104SA SG 11201701104S A SG11201701104S A SG 11201701104SA SG 11201701104S A SG11201701104S A SG 11201701104SA SG 11201701104S A SG11201701104S A SG 11201701104SA SG 11201701104S A SG11201701104S A SG 11201701104SA
Authority
SG
Singapore
Prior art keywords
morpholin
yloxy
phenyl
large scale
scale production
Prior art date
Application number
SG11201701104SA
Inventor
Ramakrishna Nirogi
Anil Karbhari Shinde
Ramasastri Kambhampati
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Publication of SG11201701104SA publication Critical patent/SG11201701104SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201701104SA 2014-08-16 2014-10-20 Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride SG11201701104SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN4010CH2014 2014-08-16
PCT/IN2014/000666 WO2016027275A1 (en) 2014-08-16 2014-10-20 Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride

Publications (1)

Publication Number Publication Date
SG11201701104SA true SG11201701104SA (en) 2017-03-30

Family

ID=52339255

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201701104SA SG11201701104SA (en) 2014-08-16 2014-10-20 Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride

Country Status (28)

Country Link
US (1) US9802896B2 (en)
EP (1) EP3180334B1 (en)
JP (1) JP6385580B2 (en)
KR (1) KR101860487B1 (en)
CN (1) CN106573925B (en)
AP (1) AP2017009753A0 (en)
AU (1) AU2014403999B2 (en)
BR (1) BR112017002922B1 (en)
CA (1) CA2957494C (en)
CY (1) CY1121253T1 (en)
DK (1) DK3180334T3 (en)
EA (1) EA032823B1 (en)
ES (1) ES2693378T3 (en)
HK (1) HK1231472A1 (en)
HR (1) HRP20181801T1 (en)
HU (1) HUE041465T2 (en)
IL (1) IL250412B (en)
LT (1) LT3180334T (en)
MX (1) MX364931B (en)
NZ (1) NZ728915A (en)
PL (1) PL3180334T3 (en)
PT (1) PT3180334T (en)
RS (1) RS57927B1 (en)
SG (1) SG11201701104SA (en)
SI (1) SI3180334T1 (en)
TR (1) TR201816175T4 (en)
WO (1) WO2016027275A1 (en)
ZA (1) ZA201700936B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202092979A1 (en) 2018-05-31 2021-03-12 Сувен Лайф Сайенсиз Лимитед METHOD FOR TREATMENT OF HISTAMIN RECEPTOR REVERSE AGONIST TYPE 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904738D0 (en) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
JP5663605B2 (en) * 2011-02-04 2015-02-04 イハラケミカル工業株式会社 Process for producing aminophenylpyrimidinyl alcohol derivative and synthetic intermediate thereof
EA023260B1 (en) 2011-02-23 2016-05-31 Сувен Лайф Сайенсиз Лимитед Novel compounds as histamine hreceptor ligands

Also Published As

Publication number Publication date
HRP20181801T1 (en) 2018-12-28
US20170260135A1 (en) 2017-09-14
AU2014403999A1 (en) 2017-02-23
TR201816175T4 (en) 2018-11-21
CN106573925B (en) 2020-04-10
IL250412A0 (en) 2017-03-30
KR20170036044A (en) 2017-03-31
EA032823B1 (en) 2019-07-31
CA2957494A1 (en) 2016-02-25
MX364931B (en) 2019-05-14
AU2014403999B2 (en) 2017-12-14
WO2016027275A1 (en) 2016-02-25
DK3180334T3 (en) 2018-11-26
HUE041465T2 (en) 2019-05-28
EA201790388A1 (en) 2017-06-30
AP2017009753A0 (en) 2017-02-28
CN106573925A (en) 2017-04-19
JP2017525761A (en) 2017-09-07
SI3180334T1 (en) 2019-01-31
PL3180334T3 (en) 2019-03-29
HK1231472A1 (en) 2017-12-22
RS57927B1 (en) 2019-01-31
KR101860487B1 (en) 2018-05-23
CA2957494C (en) 2018-08-28
ZA201700936B (en) 2019-07-31
NZ728915A (en) 2018-01-26
PT3180334T (en) 2018-11-16
MX2017002043A (en) 2017-05-04
JP6385580B2 (en) 2018-09-05
BR112017002922A2 (en) 2017-12-05
EP3180334B1 (en) 2018-09-26
LT3180334T (en) 2018-11-12
EP3180334A1 (en) 2017-06-21
ES2693378T3 (en) 2018-12-11
IL250412B (en) 2019-11-28
CY1121253T1 (en) 2020-05-29
US9802896B2 (en) 2017-10-31
BR112017002922B1 (en) 2023-01-03

Similar Documents

Publication Publication Date Title
HRP20200216T1 (en) Novel methyl-piperidine compounds useful for inhibiting microsomal prostaglandin e2 synthase-1
IL257390B (en) Salts of 1-((4-(methoxymethyl)-4-(((1r,2s)-2-phenyl-cyclopropylamine)methyl) piperidin-1-yl)methyl)-cyclobutane-carboxylic acid as lsd1 inhibitor
SI2981520T1 (en) New process for the synthesis of 1-(2-((2,4-dimethylphenyl)thio)phenyl)piperazine
IL265067B (en) Process for preparing btk inhibitors
ZA201604838B (en) Process for the production of synthesis gas
HUP1700197A2 (en) Industrial procedure for production of cariprazine
HRP20181801T1 (en) Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride
PL3322696T3 (en) Process for making hydroxyethyl piperazine compounds
DK3247699T3 (en) PROCESS FOR PRODUCTION OF 2- [4- (CYCLOPROPANCARBONYL) PHENYL] -2-METHYL-PROPANNITRIL
IL249282B (en) Process for preparing 3,5-bis(haloalkyl)pyrazoles via acylation of ketimines
IL247895A0 (en) Process for the preparation of n-[3-(benzylcarbamoyl)phenyl]-1 h-pyrazole-5-carboxamides
PT3368513T (en) Process for the synthesis of pirfenidone
TH1701000768A (en) process for large-scale production of N-[4-(1-cyclobutylpiperidin-4- yloxy)phenyl]-2-(morpholin-4-yl)acetamide dihy hydrochloride
TH169412B (en) Process for mass production. N- (4- (1-cyclobutylpiperidin-4-iloxi) phenyl] -2- (morpholin-4-il) acetamide dihydrate Chloride
TH1701000769A (en) process for large-scale production of 1-isopropyl-3-{5-[1-(3-methox cpropyl)piperidin-4-yl]-[1,3,4]oxadiazole-2-yl}-1H-indazoleoxalate
GB201523002D0 (en) Thiazolidine acid drug intermediates LN- acetyl-thia-proline synthesis method
GB201523219D0 (en) Piperidine-carboxylic acid amide pharmaceutical intermediate N- (2,6- dimethylphenoxy) - 4-pyridinecarboxamide synthesis method
PL3209661T3 (en) Process for preparing a polymorph of rivaroxaban
MX2016010549A (en) Indole carboxamides and benzimidazole carboxamides as insecticides and acaricides.